| 000 | 01650 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250516031025.0 | ||
| 264 | 0 | _c20111130 | |
| 008 | 201111s 0 0 eng d | ||
| 022 | _a1529-8809 | ||
| 024 | 7 |
_a10.1097/TA.0b013e31820932e2 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKuo, Jinn-Rung | |
| 245 | 0 | 0 |
_aAgmatine-promoted angiogenesis, neurogenesis, and inhibition of gliosis-reduced traumatic brain injury in rats. _h[electronic resource] |
| 260 |
_bThe Journal of trauma _cOct 2011 |
||
| 300 |
_aE87-93 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAgmatine _xtherapeutic use |
| 650 | 0 | 4 |
_aAngiogenesis Inducing Agents _xtherapeutic use |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBrain _xpathology |
| 650 | 0 | 4 |
_aBrain Injuries _xdrug therapy |
| 650 | 0 | 4 |
_aCerebral Infarction _xprevention & control |
| 650 | 0 | 4 |
_aGliosis _xprevention & control |
| 650 | 0 | 4 | _aIn Situ Nick-End Labeling |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMovement Disorders _xprevention & control |
| 650 | 0 | 4 |
_aNeovascularization, Physiologic _xdrug effects |
| 650 | 0 | 4 |
_aNeurogenesis _xdrug effects |
| 650 | 0 | 4 |
_aNeuroprotective Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aNitric Oxide Synthase Type I _xdrug effects |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 700 | 1 | _aLo, Chong-Jeh | |
| 700 | 1 | _aChang, Ching-Ping | |
| 700 | 1 | _aLin, Kao-Chang | |
| 700 | 1 | _aLin, Mao-Tsun | |
| 700 | 1 | _aChio, Chung-Ching | |
| 773 | 0 |
_tThe Journal of trauma _gvol. 71 _gno. 4 _gp. E87-93 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/TA.0b013e31820932e2 _zAvailable from publisher's website |
| 999 |
_c20697699 _d20697699 |
||